| Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: progress 2001-2006
| [0006]
|
| Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics
| [0006]
|
| Cell cycle kinases as therapeutic targets for cancer
| [0006]
|
| Antitumor activity of cell-permeable p18(INK4c) with enhanced membrane and tissue penetration
| [0006]
|
| Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis
| [0006]
|
| Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase
| [0006]
|
| Nuclear import of proinflammatory transcription factors is required for massive liver apoptosis induced by bacterial lipopolysaccharide
| [0006]
|
| Suppression of Staphylococcal Enterotoxin B-induced Toxicity by a Nuclear Import Inhibitor
| [0006]
|
| Suppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitor
| [0006]
|
| In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes
| [0006]
|
| Cell-.permeable NM23 blocks the maintenance and progression of established pulmonary metastasis
| [0006]
|
| Cell-permeable parkin proteins suppress Parkinson disease-associated phenotypes in cultured cells and animals
| [0006]
|
| Antitumor activity of cell-permeable RUNX3 protein in gastric cancer cells
| [0006]
|
| The effect of intracellular protein delivery on the anti-tumor activity of recombinant human endostatin
| [0006]
|
| Partial somatic to stem cell transformations induced by cell-permeable reprogramming factors
| [0006]
|
| Inducible gene targeting in mice using the Cre/lox system
| [0006]
|
| Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination
| [0006]
|
| Inducible gene targeting in mice
| [0006]
|
| Targeted oncogene activation by site-specific recombination in transgenic mice
| [0006]
|
| A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination
| [0006]
|
| CREating breakthroughs
| [0006]
|
| Genomic targeting with an MBP-Cre fusion protein
| [0006]
|
| Genomic targeting with purified Cre recombinase
| [0006]
|
| Receptor/transporter-independent targeting of functional peptides across the plasma membrane.
| [0006]
|
| Antitumor activity of cell-permeable p18(INK4c) with enhanced membrane and tissue penetration
| [0006]
|
| Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase
| [0006]
|
| Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
| [0006]
|
| Cell cycle-dependent transduction of cell-permeant Cre recombinase proteins
| [0006]
|
| Solid-Phase Peptide Synthesis
| [0124]
|
| Molecular Cloning: A Laboratory Manual
| [0125]
[0128]
|
| Current Protocols in Molecular Biology
| [0125]
|
| Gene
| [0125]
|
| Nature
| [0125]
|
| Current Protocols in Molecular Biology
| [0128]
|
| Novagen, pET System manual
| [0136]
|
| Protein Purification: Principles and Practice
| [0141]
|
| Inhibition of Nuclear Translocation of Transcription Factor NF-kB by a Synthetic peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence
| [0161]
|
| Epigenetic Regulation of Gene Structure and Function with a Cell-Permeable Cre Recombinase
| [0161]
|
| Cell-Permeable NM23 Blocks the Maintenance and Progression of Established Pulmonary Metastasis
| [0161]
|
| Antitumor Activity of Cell-Permeable p18INK4c With Enhanced Membrane and Tissue Penetration
| [0161]
|
| Antitumor Activity of Cell-Permeable RUNX3 Protein in Gastric Cancer Cells
| [0161]
|
| The Effect of Intracellular Protein Delivery on the Anti-Tumor Activity of Recombinant Human Endostatin
| [0161]
|
| Partial Somatic to Stem Cell Transformations Induced By Cell-Permeable Reprogramming Factors
| [0161]
|
| Cell-Permeable Parkin Proteins Suppress Parkinson Disease-Associated Phenotypes in Cultured Cells and Animals
| [0161]
|